De Burlo Group Inc Merck & Co., Inc. Transaction History

De Burlo Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $1.95 Million - $2.5 Million	22,300 Added 31.65%	92,750 $10.3 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $5.54 Million - $6.23 Million	65,589 Added 1349.29%	70,450 $6.07 Million
Q2 2022 Aug 11, 2022	BUY	$83.49 - $94.64 $343,227 - $389,065	4,111 Added 548.13%	4,861 $443,000
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $55,132 - $61,800	750 New	750 $61,000
Q1 2020 May 07, 2020	SELL	$63.36 - $87.82 $8.4 Million - $11.6 Million	-132,500 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$77.58 - $87.54 $4.33 Million - $4.88 Million	55,800 Added 72.75%	132,500 $12.1 Million
Q3 2019 Nov 07, 2019	BUY	$76.08 - $82.93 $5.84 Million - $6.36 Million	76,700 New	76,700 $6.46 Million
Q1 2019 May 09, 2019	SELL	$69.58 - $79.36 $10.6 Million - $12.1 Million	-152,900 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$65.24 - $75.71 $9.98 Million - $11.6 Million	152,900 New	152,900 $11.7 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of De Burlo Group Inc, based on Form 13F filings with the SEC.

Stay updated on De Burlo Group Inc with notifications on news.